SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immunomedics (IMMU)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rod K. who wrote (134)5/13/1997 10:36:00 PM
From: WWS   of 371
 
Rod, with IMMU there is no "short term". Large number of shares outstanding, and VERY slow sales growth of their only US product, CEA Scan, mean a LONG wait by shareholders until profitability. If you go back a half year or so on this thread there was someone else who got into IMMU hoping for a short term run up; it didn't happen then and won't now, IMO. While there are better stocks for speculation, IMMU is still an appropriate stock for investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News